… The main presenting symptom of all bladder cancers is painless haematuria, and the
diagnosis is established by urinary cytology and transurethral tumour resection. Intravesical …

… of the various forms of bladder cancer. A formal systematic review was not performed, but
relevant … was graded from 1 (high-quality systematic reviews and individual RCTs) to 5 (expert …

… tumours can be offered bladder-sparing trimodality treatment consisting of transurethral
resection with chemoradiation. Advanced disease is best treated with systemic cisplatin-based …

… The largest study in our series (a systematic review of 40 studies and a meta-analysis of 17
studies) showed a risk effect of 2.7 (95% CI 1.2–4.1) for 10 μg/l and 5.8 (2.9–8.7) for 140 μg/l. …

… Urothelial cancers remain the most common type of bladder cancer in North America and
Europe; however, in Egypt, 10–40% of bladder cancers are squamous cell cancers that are …

… Our systematic review of the literature on the performance (sensitivity and specificity) of urine
… with data on the same tests that were reported in reviews without this selection criterion. …

… to systematically review the benefits and harms of bladder-sparing therapies, lymph node
dissection, and systemic … for patients with clinically localized muscle-invasive bladder cancer. …

… In this systematic review we summarize evidence from the most recent articles regarding
the effects of smoking and smoking cessation on UCB development and oncologic outcomes …

… Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer … Subtyping of both forms of bladder cancer is likely to change considerably with …

… improves survival in patients with invasive bladder cancer, despite randomised controlled
trials of more than 3000 patients. We undertook a systematic review and meta-analysis to …